Wall Street
Price Targets

SGT Price Targets Summary
Seagen Inc

There are no price targets for SGT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Seagen Inc Competitors:
Price Targets
NIOX
Niox Group PLC
23% Upside
MDGL
Madrigal Pharmaceuticals Inc
1% Upside
PGEN
Precigen Inc
107% Upside
ALKS
Alkermes Plc
57% Upside
300896
Imeik Technology Development Co Ltd
39% Upside
LVTX
LAVA Therapeutics NV
20% Downside
SPRB
Spruce Biosciences Inc
154% Upside

Revenue
Forecast

Revenue Estimate
Seagen Inc

For the last 8 years the compound annual growth rate for Seagen Inc's revenue is 27%. The projected CAGR for the next 4 years is 28%.

27%
Past Growth
28%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Seagen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Seagen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-23%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SGT's stock price target?
Not Available

SGT doesn't have any price targets made by Wall Street professionals.

What is Seagen Inc's Revenue forecast?
Projected CAGR
28%

For the last 8 years the compound annual growth rate for Seagen Inc's revenue is 27%. The projected CAGR for the next 4 years is 28%.

Back to Top